We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLSU.L Regulatory News (CLSU)

  • There is currently no data for CLSU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ClearStar agreement with IntelliCentrics

28 Mar 2017 07:00

RNS Number : 6788A
ClearStar,Inc.
28 March 2017
 

 

ClearStar's Titer and Drug Screening Solution to be Integrated into IntelliCentrics' SEC3URE Program for Hospitals and Healthcare Organisations

 

ClearStar's automated order placement, registration, automatic transmission, to eliminate the traditional paper-intensive forms and inefficient way of collating data for titer and drug screening tests

 

ClearStar (AIM: CLSU and CLST), the technology and service provider to the background check industry, is pleased to announce that it has entered into a partnership with IntelliCentrics, the healthcare industry leader with over 10,000 distinct installations of vendor credentialing across the USA, Canada, and the United Kingdom.

 

Under the terms of the partnership, ClearStar's automated titer and drug screening solution will be integrated into IntelliCentrics' SEC³URE Program for Hospitals and Healthcare Organisations. The SEC³URE healthcare experience is designed to allow hospitals to control access by healthcare industry representatives (HIR), by ensuring only those that comply with the hospital's specific policies gain access to patient sensitive or restricted areas.

 

Individual hospitals decide entry requirements, which can include relevant immunisations, professional accreditations and compliance with hospital policies. A titer test measures the existence and levels of antibodies in the blood i.e. the ability to provoke a response from the immune system to disease. This response can come from natural exposure or from vaccination. Rather than hospital staff having to conduct the checks, HIRs pre-register via the SEC³URE system, which confirms their compliance status when they arrive on site.

 

With this partnership, IntelliCentrics has the tools for its members to streamline the titer and drug testing ordering and results, saving time and money. With automated order placement, registration, automatic transmission, it will eliminate the traditional paper-intensive titer and drug test forms, double data-entry, and multiple logins to the test ordering websites.

 

"Members of the IntelliCentrics community rely on us to deliver and provide the most efficient service and technology to do their jobs at peak levels while concurrently safeguarding a SEC3URE healthcare experience for everyone. Our affiliation with ClearStar advances our capability to protect our entire community," comments Mike Sheehan, Global CEO of IntelliCentrics. Sheehan continues "The partnership between IntelliCentrics and ClearStar is at the core of our belief that we all play a role in a safe and SEC3URE healthcare experience." 

 

"We are very proud to be working with IntelliCentrics with whom we share a common goal of assuring safety for the healthcare providers and patients through this new best-of-breed solution," stated Robert Vale, CEO of ClearStar. "By integrating our mobile, paperless chain of custody technology with IntelliCentrics' industry-leading service technology infrastructure, we will enable healthcare personnel to be screened and approved for work more quickly thereby meeting the aggressive time demands on the healthcare industry."

 

 

Enquiries

 

ClearStar, Inc.

Robert J. Vale, Chief Executive Officer

David Pattillo, Chief Financial Officer

+1 770 416 1900

finnCap Ltd.

Jonny Franklin-Adams, Simon Hicks - Corporate Finance

Christian Hobart, Abigail Wayne - Corporate Broking

+44 20 7220 0500

Luther Pendragon Ltd.

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

Notes to Editors

 

About ClearStar

 

ClearStar, Inc. is a leading and trusted background check technology, strategic services, and decision-making information provider to employers and background screening companies.

 

A seven-time Inc. 5000 honouree and founding member of the National Association of Professional Background Screeners, ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: www.clearstar.net.

 

About IntelliCentrics

 

IntelliCentrics, the security experts, is in the business of savings lives by creating a safe and SEC³URE healthcare experience. IntelliCentrics is uniquely qualified to help hospitals and healthcare organizations to provide high-quality patient care. By prioritizing security, IntelliCentrics facilities meet or exceed compliance best practices by letting everyone in safely. More healthcare facilities across seven countries adopt IntelliCentrics standards than all competitors combined. Now, every person entering a facility can contribute to preserving patient care, from physicians to patient visitors, vendors, volunteers, and staff. To learn more about IntelliCentrics, the leading provider of managed services to maintain compliance programs to create a safe and SEC³URE healthcare experience, please phone (817) SEC³URE or visit www.IntelliCentrics.com.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLLFEAVEIDFID
Date   Source Headline
11th Nov 202011:49 amRNSHolding(s) in Company
10th Nov 20207:00 amRNSOffer Closed
6th Nov 202010:34 amRNSHolding(s) in Company
27th Oct 20204:29 pmRNSHolding(s) in Company
26th Oct 20207:00 amRNSHolding(s) in Company
20th Oct 20201:43 pmRNSHolding(s) in Company
20th Oct 20207:30 amRNSExtension to Offer
20th Oct 20207:00 amRNSProposed cancellation of trading on AIM
19th Oct 202012:02 pmRNSHolding(s) in Company
16th Oct 202010:38 amRNSHolding(s) in Company
15th Oct 20207:00 amRNSHolding(s) in Company
12th Oct 20201:21 pmRNSChanges to the ClearStar Board
6th Oct 20203:42 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSOffer Declared Unconditional
29th Sep 20206:20 pmRNSPDMR Shareholdings
21st Sep 20207:00 amRNSHolding(s) in Company
18th Sep 20204:52 pmRNSPosting of Offer Document and Publication on Web
18th Sep 20204:40 pmRNSPDMR Shareholding
18th Sep 202010:54 amRNSHolding(s) in Company
16th Sep 20209:06 amRNSSecond Price Monitoring Extn
16th Sep 20209:01 amRNSPrice Monitoring Extension
16th Sep 20207:01 amRNSRecommended Offer
16th Sep 20207:00 amRNSInterim Results
17th Jul 20204:41 pmRNSSecond Price Monitoring Extn
17th Jul 20204:36 pmRNSPrice Monitoring Extension
17th Jul 20207:00 amRNSTrading Update
16th Jun 20205:08 pmRNSResult of AGM
16th Jun 20207:00 amRNSAGM Statement
22nd May 20207:00 amRNSNotice of AGM and Publication of Annual Report
21st May 20207:00 amRNSLaunch of COVID-19 testing service for employers
6th May 20207:00 amRNSFinal Results
26th Feb 20207:00 amRNSHolding(s) in Company
10th Feb 20207:00 amRNSFirst contract in facilities management sector
17th Dec 20197:00 amRNSTrading Update
18th Sep 20197:00 amRNSInterim Results
5th Sep 20197:00 amRNSClearStar achieves ISO security accreditation
9th Aug 20191:32 pmRNSDirector Share Purchase
8th Aug 20197:00 amRNSAccelerated Growth in MIS and Notice of Results
2nd Aug 20196:02 pmRNSHolding(s) in Company
16th Jul 20197:00 amRNSTodd Shoulberg promoted to President, MIS
10th Jul 20197:00 amRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSTrading Update
19th Jun 20192:49 pmRNSDirector Share Purchase
18th Jun 20194:47 pmRNSResult of AGM
18th Jun 20197:00 amRNSAGM Statement
5th Jun 201912:37 pmRNSPDMR Share Purchase
31st May 20196:30 pmRNSNotice of AGM and Publication of Annual Report
31st May 20194:09 pmRNSHolding(s) in Company
31st May 201912:13 pmRNSNotice of AGM and Publication of Annual Report
28th May 20197:00 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.